Oropharyngeal cancer symptoms vary by HPV status

This article originally appeared here.
Share this content:
Oropharyngeal cancer symptoms vary by HPV status
Oropharyngeal cancer symptoms vary by HPV status

(HealthDay News) -- Initial symptom presentation seems to differ for human papillomavirus (HPV)-positive versus HPV-negative patients with oropharyngeal squamous cell carcinoma (OPSCC), according to a study published online March 20 in JAMA Otololaryngology.

Wesley R. McIlwain, from the Medical University of South Carolina in Charleston, and colleagues retrospectively reviewed the medical records of previously untreated patients with OPSCC diagnosed from Jan.1, 2008, to May 20, 2013, who were evaluated by one physician. The most common initial symptoms were identified and compared for HPV-positive and HPV-negative tumors.

The researchers found that the most common initial symptoms in OSPCC were neck mass (44 percent) and sore throat (33 percent). Compared with HPV-negative patients, HPV-positive patients were significantly more likely to initially notice a neck mass (51 versus 18 percent; P = 0.02). HPV-negative patients were more likely to notice sore throat (53 versus 28 percent; P = 0.09), dysphagia (41 versus 10 percent; P = 0.05), or odynophagia (24 versus 6 percent; P = 0.04).

"The differences in clinical presentation between HPV-positive and HPV-negative OPSCC may better support the ongoing theory of how HPV-positive OPSCC tends to originate in the tonsillar crypts resulting in early cervical metastasis, and that HPV-negative OPSCC is more likely to be locally invasive correlating with initial symptoms at the primary tumor site," the authors write.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs